Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 11 Show results per page	View Search Criteria \| Help With Results

Last Modified: 5/15/2008 First Published: 7/23/2006


1.		Phase III Randomized Chemoprevention Study of Esomeprazole With Versus Without Acetylsalicyclic Acid (Aspirin) in Preventing Esophageal Cancer in Patients With Barrett's Metaplasia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Prevention				Active				18 and over				Other, Pharmaceutical / Industry				OCTO-ASPECT RADCLIFFE-32, ZENECA-RADCLIFFE-32, EUDRACT-2004-003836-77, ISRCTN85156844, EU-20628, NCT00357682


2.		Chemoprevention of Colorectal Adenomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Active				40 to 75				Pharmaceutical / Industry				COLO CP-01-US NCT00486512

Last Modified: 12/17/2008 First Published: 11/28/2007


3.		Phase III Randomized Study of Acetylsalicylic Acid (Aspirin) in Patients With Completely Resected Dukes Stage C Colon or Rectal Cancer, Dukes Stage B Rectal Cancer, or High-Risk Dukes Stage B Colon Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				21 and over				Other				SINGAPORE-ICR-02 ICR-02, SINGAPORE-ASCOLT, NCT00565708, SINGAPORE-07-32-LGI


4.		A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				18 and over				Other				05-0427 NCT00263211

Last Modified: 10/20/2008 First Published: 5/11/2007


5.		Phase II Randomized Chemoprevention Study of Esomeprazole Magnesium With Versus Without Acetylsalicylic Acid (Aspirin) in Patients With Barrett Esophagus

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Prevention				Active				18 and over				NCI				MAYO-MAY04-4-01 MAY04-4-01, NCT00474903


6.		A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				RV-PI-0103 07/04, NCT00482261


7.		Trial of Aspirin and Arginine Restriction in Colon Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				18 to 80				Other				UCI 07-47 NCT00578721


8.		Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				2007-0266 NCT00790452

Last Modified: 10/12/2007 First Published: 4/23/2007


9.		Phase II Randomized Chemoprevention Study of Acetylsalicylic Acid (Aspirin) in Patients at Increased Risk for the Development or Recurrence of Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Prevention				Active				Under 75				NCI				NU-NWU04-2-03 NWU04-2-03, NCT00468910


10.		Effects of ASA on Prostate Tissue

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Prevention				Active				45 to 74				Other				05-7956-01 NCT00234299

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute